Nipocalimab in Moderate to Severe Sjogren's Disease

Clinical trial NCT06741969 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06741969
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sjogrens Syndrome

Start date: 2024-12-04
Primary completion: 2028-01-01
Enrollment: 655

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.